Clinical Trials on Phosphorus and Calcium Disorders

Total 141754 results

Carmel Medical Center

Unknown

The Relationship Between Ca Intake , Blood Level of Ca, PTH, TSH, Vitamin D, and Urine Ca, P and Cardiac Calcium Scoring (TSHPTHCA)

Disorders of Phosphorus and Calcium Metabolism
Azienda Ospedaliero-Universitaria di Modena

Completed

Reliability of Serum Calcium to Phosphorus (Ca/P) Ratio as an Accurate and Inexpensive Tool to Define Disorders of Ca-P Metabolism

Phosphorus and Calcium Disorders

Italy
King Faisal Specialist Hospital & Research Center

Completed

Rate of Termination of Premixed Parenteral Nutrition (PN) in Surgical Patients Secondary to High Serum Electrolytes

Hyperphosphatemia | Hyperkalemia | Hypercalcemia | Hypermagnesemia

Saudi Arabia
Azienda Ospedaliero-Universitaria di Modena

Completed

Serum Calcium to Phosphorous (Ca/P) Ratio in the Diagnosis of Ca-P Metabolism Disorders: a Multicentre Study

Hyperparathyroidism | Parathyroid Diseases | Hypoparathyroidism | Phosphorus and Calcium Disorders

Italy
National Taiwan University Hospital

Unknown

Observing the Changes of Fibroblast Growth Factor 23 in Patients of Tumor Induced Osteomalacia

Hypophosphatemia

Taiwan
University of Minnesota
Indiana University

Active, not recruiting

Calcium and Phosphorus Whole-Body Balance and Kinetics in Patients With Moderate Chronic Kidney Disease

Chronic Kidney Diseases | Phosphorus and Calcium Disorders | Chronic Kidney Disease Mineral and Bone Disorder

United States
National Institute of Dental and Craniofacial Research...

Terminated

Cinacalcet for Fibroblast Growth Factor 23 (FGF23)-Mediated Hypophosphatemia (Hypophosphatemic Rickets)

Osteomalacia

United States
Medical University of Warsaw
Polish Academy of Sciences; University of Warsaw

Completed

The Effect of Bicarbonate Profiling in Dialysis Fluid on Phosphate Removal During Hemodialysis and Blood pH

Phosphorus Metabolism Disorders | Acid-Base Balance Disorder

Poland
Yale University
National Center for Advancing Translational Sciences (NCATS)

Suspended

The Impact of Phosphate Metabolism on Healthy Aging

Rickets | Hypophosphatemia | Hypercalciuria | XLH | HHRH

United States
Kyowa Kirin Korea Co., Ltd.

Recruiting

Post Marketing Surveillance Study to Observe Safety and Effectiveness of NEPHOXIL ® in S. Korea Patients

Hyperphosphatemia

Korea, Republic of
Kyowa Kirin Co., Ltd.

Completed

A Phosphate Binder Switch Study of KHK7791 in Hyperphosphatemia Patients on HD

Hyperphosphatemia

Japan
Kyowa Kirin Co., Ltd.

Completed

Phosphate Binder Switch Study of KHK7791 in Hyperphosphatemia Patients on Hemodialysis

Hyperphosphatemia

Japan
Bayer

Completed

Fosrenol Post-marketing Surveillance for Continuous Cyclic Peritoneal Dialysis in Japan (FOSRENOL-CAPD)

Hyperphosphatemia

Japan
Bayer

Completed

Bioequivalence Study of BAY77-1931 Granule

Hyperphosphatemia

Japan
Washington University School of Medicine

Completed

The Effect of Oral Niacinamide on Plasma Phosphorus Levels in Peritoneal Dialysis Patients

Hyperphosphatemia

United States
Grand Life Science (Liaoning) Co., Ltd.
The First Hospital of Jilin University

Recruiting

To Evaluate the Patient Tolerance, Pharmacodynamics and Pharmacokinetics of Lanthanum Polystyrene Sulfonate Powder

Hyperphosphatemia

China
Kyowa Kirin Co., Ltd.

Completed

Phosphate Binder-combination Study of KHK7791 in Hyperphosphatemia Patients

Hyperphosphatemia

Japan
Kyowa Kirin Co., Ltd.

Completed

Clinical Study of KHK7791 in Hyperphosphatemia Patients on Peritoneal Dialysis

Hyperphosphatemia

Japan
Kyowa Kirin Co., Ltd.

Completed

Clinical Study of KHK7791 in Hyperphosphatemia Patients on Hemodialysis

Hyperphosphatemia

Japan
RWTH Aachen University

Terminated

Velphoro and Impact on the Oral Cavity and Gut Microbiome (MicrobiomEisen)

Hyperphosphatemia

Germany
MetroHealth Medical Center

Completed

Phosphorus Improvement Pilot Study

Hyperphosphatemia
Taipei Medical University WanFang Hospital

Unknown

The Influence of Dietary Phosphorus Education Program on Nutritional Status and Serum Phosphate Level Among Hemodialysis Patient

Malnutrition | Hyperphosphatemia

Taiwan
Fresenius Medical Care North America
Renal Research Institute

Completed

Phosphate Kinetic Modeling 2 (PKM2)

ESRD | Hyperphosphatemia

United States
Bayer

Completed

Long-term Treatment on BAY77-1931 (Lanthanum Carbonate) to Measure Lanthanum Concentrations in Bone

Hyperphosphatemia | Dialysis

Japan
Soad Elsayed Abu douh

Not yet recruiting

Markers of Metabolism and Vascular Access in ESRD

Disorders of Calcium and Bone Metabolism
Kissei Pharmaceutical Co., Ltd.

Completed

A Phase III Study of PA21 in Hemodialysis Patients With Hyperphosphatemia

Hemodialysis | Hyperphosphatemia

Japan
Kyowa Kirin Co., Ltd.

Completed

Dose-finding Study of KHK7791 in Hyperphosphatemia Patients

Hyperphosphatemia

Japan
Ardelyx

Completed

A Phase 3 Study of Tenapanor to Treat Hyperphosphatemia in ESRD Patients on Dialysis

Hyperphosphatemia

United States
Kaiser Permanente
Keryx Biopharmaceuticals

Completed

Transition to Ferric Citrate Among Hemodialysis and Peritoneal Dialysis Patients

Hyperphosphatemia

United States
Kyowa Kirin Co., Ltd.

Completed

Phosphate Binder-combination Study of KHK7791 in Hyperphosphatemia Patients on Hemodialysis

Hyperphosphatemia

Japan
Shire

Completed

Long-term Effect of Lanthanum Carbonate on Bone

Hyperphosphatemia

United States, Germany, United Kingdom
Bayer

Completed

Fosrenol Post-marketing Surveillance for Hemodialysis in Japan (FOSRENOL-HD)

Hyperphosphatemia

Japan
Vifor Fresenius Medical Care Renal Pharma

Completed

Non-interventional Study to Investigate the Short and Long Term Real-life Safety, Effectiveness, and Adherence of Velphoro® in Patients With Hyperphosphataemia Undergoing Haemodialysis (HD) or Peritoneal Dialysis (PD) (VERIFIE)

Hyperphosphatemia

Spain, Netherlands, Germany, Italy, France, Greece, United Kingdom
Jiujiang No.1 People's Hospital

Unknown

Nicotinic Acid in Hemodialysis Patients With Hyperphosphatemia (NAHPH)

Hyperphosphatemia

China
Rijnstate Hospital

Completed

FGF-23 Suppressibility by Calcitonin

Hypophosphatemia

Netherlands
Shiraz University of Medical Sciences

Completed

The Effect of Magnesium Oxide on Plasma Phosphate in Hemodialysis Patients

Hyperphosphatemia

Iran, Islamic Republic of
Bayer

Completed

BAY 77-1931 Long-term Extension From Phase II Study

Hyperphosphatemia

Japan
Shanghai Jiao Tong University School of Medicine
Baxter Healthcare Corporation

Unknown

The Effect of Systemic Dietary Instruction on Management of Plasma Phosphorus Levels in Peritoneal Dialysis (PD) Patients

Hyperphosphatemia

China
Bezmialem Vakif University
Didem Ertorul

Completed

The Status of Parathyroid Hormone Secretion in Covid-19 Patients

COVID-19 Infection | Parathyroid Hormone | Parathyroid Gland | Calcium | Phosphorus | Alkaline Phosphatase

Turkey
Medical University of Graz
Dentsply Sirona Implants

Completed

Biphasic Calcium Phosphate vs. Hydroxyapatite in Sinus Floor Elevation

Sinus Floor Augmentation | Bone Substitutes | Hydroxyapatite | Calcium Phosphates | Rhodophyta
Romanian Society of Nephrology

Withdrawn

Arterial Stiffness and Calcifications in Haemodialysis Patients on Sevelamer or Calcium Acetate

Hyperphosphatemia | Haemodialyzed Patients

Romania
Fresenius Medical Care Deutschland GmbH
Siro Clinpharm Germany GmbH

Completed

Non-interventional Study to Evaluate the Ease of Reaching Individual Goals in Serum Phosphorus (Steering) (Steering)

ESRD | Hyperphosphataemia

United Kingdom, Spain, Denmark, Germany
Kissei Pharmaceutical Co., Ltd.

Completed

A Phase III Study of PA21 With Calcium Carbonate in Hemodialysis Patients With Hyperphosphatemia

Hemodialysis | Hyperphosphatemia

Japan
University Hospital, Geneva

Completed

Newborn Phosphocalcic Metabolism After Intravenous Iron Administration During Pregnancy

Iron Induced Hypophosphatemia

Switzerland
Hospital Universitari de Bellvitge
Vifor Pharma

Active, not recruiting

mHealth for Phosphorus Management in CKD. (PHOSFO_OK)

Dialysis Related Complication

Spain
Chugai Pharma Taiwan

Completed

Long Term Evaluation of Sevelamer HCl vs. Calcium-based Phosphate Binder in the Treatment of Hyperphosphatemia in Hemodialysis Patients

Hemodialysis | Hyperphosphatemia | Cardiovascular Events
University College Cork
Cork University Hospital; Irish Nutrition & Dietetic Institute

Completed

Decreasing Intakes & Absorption of Phosphorus in Haemodialysis Patients Through Food Choices (DIP HD)

Hyperphosphatemia | Dietary Modification | Renal Dialysis

Ireland
Miulli General Hospital

Completed

Calcium Concentration in Bicarbonate Hemodialysis (HD)

Calcium Mass Balances and Serum Calcium Profiling in hd Patients

Italy
Chen Jing
Shanghai Tongji Hospital, Tongji University School of Medicine; Huadong Hospital

Completed

Individualized Treatment of Hyperphosphatemia in Maintenance Hemodialysis Patients

Hyperphosphatemia | Maintenance Hemodialysis

China
Daiichi Sankyo, Inc.

Completed

DS2330b Alone and With Sevelamer in Patients on Chronic Hemodialysis

Hyperphosphatemia

United States

Clinical Trials on Phosphorus and Calcium Disorders

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Peru

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations